Skip to content
Yog Pharma
Anti-infectivesFluoroquinolone antibiotic

Ciprofloxacin Hydrochloride is a fluoroquinolone antibiotic indicated for urinary tract, respiratory tract, bone and joint, and gastrointestinal infections. We supply it to US manufacturers of tablets, ophthalmic solution and otic solution.

CAS86393-32-0385.8 g/molC17H21ClFN3O4
2D structure of Ciprofloxacin Hydrochloride, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 62998) and FDA’s substance registry

CAS number

86393-32-0

Molecular formula

C17H21ClFN3O4

Molecular weight

385.8g/mol

FDA UNII

IUPAC name

1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride

InChIKey

ARPUHYJMCVWYCZ-UHFFFAOYSA-N

Appearance
Faintly yellowish to light yellow crystalline substance.
Solubility
Sparingly soluble in water, slightly soluble in methanol and very slightly soluble in dehydrated alcohol.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

The hydrochloride monohydrate is the salt used in tablets. Injections and oral suspension use ciprofloxacin base, a separate API.

On the US market

Reference product
CiproNDA 019537
Approved ANDAs
16 with a marketed product
Approved forms and strengths
  • Tablet 250 mg, 500 mg, 750 mg
  • Ophthalmic solution 0.3%
  • Otic solution 0.2%
  • Ophthalmic ointment 0.3%

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com